Skip to main content
TipRanks
Go Ultimate75% OFF

Delta-Fly Pharma, Inc. (4598) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Delta-Fly Pharma, Inc. has a market cap or net worth of JPY 1.25B. The enterprise value is JPY 1.72B.

Market Cap
JPY 1.25B
Enterprise Value
JPY 1.72B

Share Statistics

Delta-Fly Pharma, Inc. has 20,195,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
20,195,000
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Delta-Fly Pharma, Inc.’s return on equity (ROE) is -47.85 and return on invested capital (ROIC) is -4723.63%.

Return on Equity (ROE)
-47.85
Return on Assets (ROA)
-6.59
Return on Invested Capital (ROIC)
-4723.63%
Return on Capital Employed (ROCE)
-47.24
Revenue Per Employee
0
Profits Per Employee
-135.50M
Employee Count
12
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Delta-Fly Pharma, Inc. is -0.45. Delta-Fly Pharma, Inc.’s PEG ratio is -0.02.

PE Ratio
-0.45
PS Ratio
0.00
PB Ratio
-4.35
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
-0.02

Income Statement

In the last 12 months, Delta-Fly Pharma, Inc. had revenue of 0 and earned -1.63B in profits. Earnings per share was -140.45.

Revenue
0
Gross Profit
-1.44M
Operating Income
-1.61B
Pretax Income
-1.62B
Net Income
-1.63B
EBITDA
-1.60B
Earnings Per Share (EPS)
-140.45

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Delta-Fly Pharma, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
-193.90%

Stock Price Statistics

Beta
0.46
52-Week Price Change
-87.45%
50-Day Moving Average
93.28
200-Day Moving Average
147.47
Relative Strength Index (RSI)
31.32
Average Volume (3m)
1.42M

Important Dates

Delta-Fly Pharma, Inc. upcoming earnings date is Feb 16, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Feb 16, 2027
Ex-Dividend Date
―

Financial Position

Delta-Fly Pharma, Inc. as a current ratio of 0.98, with Debt / Equity ratio of 0.00%

Current Ratio
0.98
Quick Ratio
0.98
Debt to Market Cap
0.00
Net Debt to EBITDA
0.09
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Delta-Fly Pharma, Inc. has paid 2.50M in taxes.

Income Tax
2.50M
Effective Tax Rate
-0.00

Enterprise Valuation

Delta-Fly Pharma, Inc. EV to EBITDA ratio is -0.48, with an EV/FCF ratio of 0.00.

EV to Sales
0.00
EV to EBITDA
-0.48
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Delta-Fly Pharma, Inc. has JPY 83.33M in cash and marketable securities with JPY 0.00 in debt, giving a net cash position of JPY 83.33M billion.

Cash & Marketable Securities
JPY 83.33M
Total Debt
JPY 0.00
Net Cash
JPY 83.33M
Net Cash Per Share
JPY 4.13
Tangible Book Value Per Share
-JPY 14.01

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Delta-Fly Pharma, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
20.94%

Scores

Smart Score
―
AI Score
42